Literature DB >> 22632926

Delirium and decisional incapacity in veterans with schizophrenia and medical illness.

Linda Ganzini1, David Mansoor, Robert Socherman, Jonathan Duckart.   

Abstract

OBJECTIVE: The objective was to examine the characteristics of Veterans with schizophrenia admitted for nonpsychiatric hospitalizations.
METHOD: We conducted a review of the electronic medical record and data warehouse downloads of Veterans with schizophrenia admitted to nonpsychiatric services of a large, academic Veterans Affairs hospital between 2004 and 2009 on whom psychiatry was consulted.
RESULTS: Seventy-four veterans were admitted 89 times. Their mean age was 62 years. Among these veterans, the most common reasons for nonpsychiatric admission were infection, cardiac disease or altered mental status. Thirty-three percent of consultations were for patients who required intensive care. Consultation was requested most frequently for assessing psychotropic medication, decision-making capacity or altered mental status, or for assistance with behavioral problems. Thirty-seven percent of patients were diagnosed with delirium, and 42% lacked decision-making capacity, mostly secondary to delirium. Twenty-seven percent of patients died during the study period.
CONCLUSION: In an aging cohort of Veterans with schizophrenia, a substantial proportion of patients developed delirium, lost decision-making capacity and required intensive care during nonpsychiatric hospital admission. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22632926     DOI: 10.1016/j.genhosppsych.2012.04.003

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  1 in total

1.  The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review.

Authors:  Enric Vincens Pons; Luis Salvador-Carulla; Alfredo Calcedo-Barba; Silvia Paz; Thomas Messer; Bruno Paccardi; Scott L Zeller
Journal:  Health Sci Rep       Date:  2020-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.